CLOSEOUT LETTER
House of Webster, Inc MARCS-CMS 492699 —
- Recipient:
- House of Webster, Inc
United States
- Issuing Office:
United States
|
|
|
|
Dallas District Office
4040 N. Central Expressway, Suite 300 Dallas, Texas 75204 |
April 19, 2017
UPS Overnight
John Griffin, President
House of Webster, Inc.
111 South Cherokee Street
Muskogee, Oklahoma 74403
Dear Mr. Griffin:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter (2016-DAL-WL-21, May 3, 2016). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
John W. Diehl
Acting Director, Compliance Branch
Dallas District
Cc:
Ryan T. Funa, General Manager
House of Webster, Inc.
1013 North 2nd Street
Rogers, Arkansas 72756